{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:40:32Z","timestamp":1778917232992,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Objective measures of disease progression are critically needed in research on Parkinson\u2019s disease (PD) and atypical Parkinsonism but may be hindered by both practicality and cost. The Purdue Pegboard Test (PPT) is objective, has high test-retest reliability, and has a low cost. The goals of this study were to determine: (1) longitudinal changes in PPT in a multisite cohort of patients with PD, atypical Parkinsonism, and healthy controls; (2) whether PPT performance reflects brain pathology revealed by neuroimaging; (3) quantify kinematic deficits shown by PD patients during PPT. Parkinsonian patients showed a decline in PPT performance that correlated with motor symptom progression, which was not seen in controls. Neuroimaging measures from basal ganglia were significant predictors of PPT performance in PD, whereas cortical, basal ganglia, and cerebellar regions were predictors for atypical Parkinsonism. Accelerometry in a subset of PD patients showed a diminished range of acceleration and irregular patterns of acceleration, which correlated with PPT scores.<\/jats:p>","DOI":"10.1038\/s41531-023-00521-0","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:03:08Z","timestamp":1685988188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson\u2019s disease and atypical parkinsonism"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-3505","authenticated-orcid":false,"given":"Bradley J.","family":"Wilkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-7207","authenticated-orcid":false,"given":"Emily R.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-1205","authenticated-orcid":false,"given":"David J.","family":"Arpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-en","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6247-9358","authenticated-orcid":false,"given":"Michael S.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Jaffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-8857","authenticated-orcid":false,"given":"Nikolaus R.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Corcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Vaillancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"521_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li, T. & Le, W. Biomarkers for Parkinson\u2019s disease: how good are they? Neurosci. Bull. 36, 183\u2013194 (2020).","journal-title":"Neurosci. Bull."},{"key":"521_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1177\/0271678X20958755","volume":"41","author":"J Brumberg","year":"2021","unstructured":"Brumberg, J. et al. Simplified quantification of [18F]FE-PE2I PET in Parkinson\u2019s disease: discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium. J. Cereb. Blood Flow Metab. 41, 1291\u20131300 (2021).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"521_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00676-4","volume":"10","author":"VS Kerstens","year":"2020","unstructured":"Kerstens, V. S. et al. Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson\u2019s disease. EJNMMI Res. 10, 95 (2020).","journal-title":"EJNMMI Res."},{"key":"521_CR4","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awv136","volume":"138","author":"E Ofori","year":"2015","unstructured":"Ofori, E. et al. Longitudinal changes in free-water within the substantia nigra of Parkinson\u2019s disease. Brain 138, 2322\u20132331 (2015).","journal-title":"Brain"},{"key":"521_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-019-0537-2","volume":"9","author":"SR Suwijn","year":"2019","unstructured":"Suwijn, S. R., Verschuur, C. V. M., Slim, M. A., Booij, J. & de Bie, R. M. A. Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson\u2019s disease. EJNMMI Res. 9, 63 (2019).","journal-title":"EJNMMI Res."},{"key":"521_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee, C. S. et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann. Neurol. 47, 493\u2013503 (2000).","journal-title":"Ann. Neurol."},{"key":"521_CR7","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1093\/brain\/awr233","volume":"134","author":"R Nandhagopal","year":"2011","unstructured":"Nandhagopal, R. et al. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson\u2019s disease. Brain 134, 3290\u20133298 (2011).","journal-title":"Brain"},{"key":"521_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2018.04.025","volume":"53","author":"N Hattori","year":"2018","unstructured":"Hattori, N. et al. Efficacy and safety of adjunctive rasagiline in Japanese Parkinson\u2019s disease patients with wearing-off phenomena: a phase 2\/3, randomized, double-blind, placebo-controlled, multicenter study. Parkinsonism Relat. Disord. 53, 21\u201327 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"521_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamaneurol.2019.4200","volume":"77","author":"FL Pagan","year":"2020","unstructured":"Pagan, F. L. et al. Nilotinib effects on safety, tolerability, and potential biomarkers in Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 77, 309\u2013317 (2020).","journal-title":"JAMA Neurol."},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","volume":"20","author":"GU H\u00f6glinger","year":"2021","unstructured":"H\u00f6glinger, G. U. et al. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial. Lancet Neurol. 20, 182\u2013192 (2021).","journal-title":"Lancet Neurol."},{"key":"521_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(18)30405-8","volume":"18","author":"PA LeWitt","year":"2019","unstructured":"LeWitt, P. A. et al. Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol. 18, 145\u2013154 (2019).","journal-title":"Lancet Neurol."},{"key":"521_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1474-4422(19)30396-5","volume":"19","author":"CW Olanow","year":"2020","unstructured":"Olanow, C. W. et al. Apomorphine sublingual film for off episodes in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled phase 3 study. Lancet Neurol. 19, 135\u2013144 (2020).","journal-title":"Lancet Neurol."},{"key":"521_CR13","doi-asserted-by":"publisher","first-page":"7304205050p1","DOI":"10.5014\/ajot.2019.031112","volume":"73","author":"EL Proud","year":"2019","unstructured":"Proud, E. L., Bilney, B., Miller, K. J., Morris, M. E. & McGinley, J. L. Measuring hand dexterity in people with Parkinson\u2019s disease: reliability of Pegboard tests. Am. J. Occup. Ther. 73, 7304205050p1\u20137304205050p8 (2019).","journal-title":"Am. J. Occup. Ther."},{"key":"521_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mus.21856","volume":"43","author":"N Amirjani","year":"2011","unstructured":"Amirjani, N., Ashworth, N. L., Olson, J. L., Morhart, M. & Chan, K. M. Validity and reliability of the Purdue Pegboard test in carpal tunnel syndrome. Muscle Nerve 43, 171\u2013177 (2011).","journal-title":"Muscle Nerve"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5014\/ajot.57.1.108","volume":"57","author":"J Gallus","year":"2003","unstructured":"Gallus, J. & Mathiowetz, V. Test-retest reliability of the Purdue Pegboard for persons with multiple sclerosis. Am. J. Occup. Ther. 57, 108\u2013111 (2003).","journal-title":"Am. J. Occup. Ther."},{"key":"521_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1589\/jpts.32.210","volume":"32","author":"K Irie","year":"2020","unstructured":"Irie, K., Iseki, H., Okamoto, K., Nishimura, S. & Kagechika, K. Introduction of the Purdue Pegboard Test for fine assessment of severity of cervical myelopathy before and after surgery. J. Phys. Ther. Sci. 32, 210\u2013214 (2020).","journal-title":"J. Phys. Ther. Sci."},{"key":"521_CR17","doi-asserted-by":"publisher","first-page":"rkab029","DOI":"10.1093\/rap\/rkab029","volume":"5","author":"K Keramiotou","year":"2021","unstructured":"Keramiotou, K. et al. Impaired hand function and performance in activities of daily living in systemic lupus erythematosus, even in patients achieving lupus low disease activity state (LLDAS). Rheumatol. Adv. Prac. 5, rkab029 (2021).","journal-title":"Rheumatol. Adv. Prac."},{"key":"521_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/09638289509166638","volume":"17","author":"J Desrosiers","year":"1995","unstructured":"Desrosiers, J., H\u00e9bert, R., Bravo, G. & Dutil, E. The Purdue Pegboard Test: normative data for people aged 60 and over. Disabil. Rehabil. 17, 217\u2013224 (1995).","journal-title":"Disabil. Rehabil."},{"key":"521_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/gps.5492","volume":"36","author":"JT Hinkle","year":"2021","unstructured":"Hinkle, J. T. & Pontone, G. M. Psychomotor processing and functional decline in Parkinson\u2019s disease predicted by the Purdue Pegboard test. Int. J. Geriatr. Psychiatry 36, 909\u2013916 (2021).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"521_CR20","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1002\/mds.28763","volume":"36","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Longitudinal changes in Parkinson\u2019s disease symptoms with and without rapid eye movement sleep behavior disorder: the Oxford Discovery cohort study. Mov. Disord. 36, 2821\u20132832 (2021).","journal-title":"Mov. Disord."},{"key":"521_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-110","volume":"10","author":"LE Dibble","year":"2010","unstructured":"Dibble, L. E. et al. Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study. BMC Neurol. 10, 110 (2010).","journal-title":"BMC Neurol."},{"key":"521_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.02.006","volume":"25","author":"TD Ellis","year":"2016","unstructured":"Ellis, T. D. et al. Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat. Disord. 25, 65\u201371 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"521_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jnnp.2009.173740","volume":"81","author":"C Zampieri","year":"2010","unstructured":"Zampieri, C. et al. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 81, 171\u2013176 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"521_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fneur.2018.00897","volume":"9","author":"L Fernandez","year":"2018","unstructured":"Fernandez, L., Huys, R., Issartel, J., Azulay, J.-P. & Eusebio, A. Movement speed-accuracy trade-off in Parkinson\u2019s disease. Front. Neurol. 9, 897 (2018).","journal-title":"Front. Neurol."},{"key":"521_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1212\/WNL.0000000000002985","volume":"87","author":"RG Burciu","year":"2016","unstructured":"Burciu, R. G. et al. Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes. Neurology 87, 709\u2013717 (2016).","journal-title":"Neurology"},{"key":"521_CR26","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/brain\/awx146","volume":"140","author":"RG Burciu","year":"2017","unstructured":"Burciu, R. G. et al. Progression marker of Parkinson\u2019s disease: a 4-year multi-site imaging study. Brain 140, 2183\u20132192 (2017).","journal-title":"Brain"},{"key":"521_CR27","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1002\/hbm.23213","volume":"37","author":"RG Burciu","year":"2016","unstructured":"Burciu, R. G. et al. Free-water and BOLD imaging changes in Parkinson\u2019s disease patients chronically treated with a MAO-B inhibitor. Hum. Brain Mapp. 37, 2894\u20132903 (2016).","journal-title":"Hum. Brain Mapp."},{"key":"521_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00429-019-02017-1","volume":"225","author":"M Febo","year":"2020","unstructured":"Febo, M. et al. Diffusion magnetic resonance imaging-derived free water detects neurodegenerative pattern induced by interferon-\u03b3. Brain Struct. Funct. 225, 427\u2013439 (2020).","journal-title":"Brain Struct. Funct."},{"key":"521_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori, E. et al. Free water improves detection of changes in the substantia nigra in parkinsonism: a multisite study. Mov. Disord. 32, 1457\u20131464 (2017).","journal-title":"Mov. Disord."},{"key":"521_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","volume":"36","author":"E Ofori","year":"2015","unstructured":"Ofori, E. et al. Increased free water in the substantia nigra of Parkinson\u2019s disease: a single-site and multi-site study. Neurobiol. Aging 36, 1097\u20131104 (2015).","journal-title":"Neurobiol. Aging"},{"key":"521_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/brain\/awv361","volume":"139","author":"PJ Planetta","year":"2016","unstructured":"Planetta, P. J. et al. Free-water imaging in Parkinson\u2019s disease and atypical parkinsonism. Brain 139, 495\u2013508 (2016).","journal-title":"Brain"},{"key":"521_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","volume":"17","author":"KA Schindlbeck","year":"2018","unstructured":"Schindlbeck, K. A. & Eidelberg, D. Network imaging biomarkers: insights and clinical applications in Parkinson\u2019s disease. Lancet Neurol. 17, 629\u2013640 (2018).","journal-title":"Lancet Neurol."},{"key":"521_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cortex.2017.03.016","volume":"92","author":"M Tahmasian","year":"2017","unstructured":"Tahmasian, M. et al. Resting-state functional reorganization in Parkinson\u2019s disease: an activation likelihood estimation meta-analysis. Cortex 92, 119\u2013138 (2017).","journal-title":"Cortex"},{"key":"521_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1073\/pnas.88.6.2297","volume":"88","author":"SM Pincus","year":"1991","unstructured":"Pincus, S. M. Approximate entropy as a measure of system complexity. Proc. Natl Acad. Sci. USA 88, 2297\u20132301 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"521_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/jamaneurol.2018.0809","volume":"75","author":"A Zhan","year":"2018","unstructured":"Zhan, A. et al. Using smartphones and machine learning to quantify Parkinson disease severity: the mobile Parkinson disease score. JAMA Neurol. 75, 876\u2013880 (2018).","journal-title":"JAMA Neurol."},{"key":"521_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/mds.28312","volume":"36","author":"H Iwaki","year":"2021","unstructured":"Iwaki, H. et al. Differences in the presentation and progression of Parkinson\u2019s disease by sex. Mov. Disord. 36, 106\u2013117 (2021).","journal-title":"Mov. Disord."},{"key":"521_CR37","doi-asserted-by":"publisher","first-page":"103022","DOI":"10.1016\/j.nicl.2022.103022","volume":"34","author":"T Mitchell","year":"2022","unstructured":"Mitchell, T. et al. Advanced diffusion imaging to track progression in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Neuroimage Clin. 34, 103022 (2022).","journal-title":"Neuroimage Clin."},{"key":"521_CR38","doi-asserted-by":"publisher","first-page":"1095441","DOI":"10.3389\/fncir.2023.1095441","volume":"17","author":"C Lin","year":"2023","unstructured":"Lin, C., Ridder, M. C. & Sah, P. The PPN and motor control: preclinical studies to deep brain stimulation for Parkinson\u2019s disease. Front. Neural Circuits 17, 1095441 (2023).","journal-title":"Front. Neural Circuits"},{"key":"521_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1750-3639.2007.00054.x","volume":"17","author":"DW Dickson","year":"2007","unstructured":"Dickson, D. W., Rademakers, R. & Hutton, M. L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 17, 74\u201382 (2007).","journal-title":"Brain Pathol."},{"key":"521_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.410410111","volume":"41","author":"FJ Vingerhoets","year":"1997","unstructured":"Vingerhoets, F. J., Schulzer, M., Calne, D. B. & Snow, B. J. Which clinical sign of Parkinson\u2019s disease best reflects the nigrostriatal lesion? Ann. Neurol. 41, 58\u201364 (1997).","journal-title":"Ann. Neurol."},{"key":"521_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1353-8020(01)00010-4","volume":"8","author":"T M\u00fcller","year":"2002","unstructured":"M\u00fcller, T. & Benz, S. Quantification of the dopaminergic response in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 8, 181\u2013186 (2002).","journal-title":"Parkinsonism Relat. Disord."},{"key":"521_CR42","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.wneu.2018.04.014","volume":"115","author":"T Nozaki","year":"2018","unstructured":"Nozaki, T. et al. Effect of subthalamic deep brain stimulation on upper limb dexterity in patients with Parkinson disease. World Neurosurg. 115, e206\u2013e217 (2018).","journal-title":"World Neurosurg."},{"key":"521_CR43","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/S1388-2457(00)00467-3","volume":"111","author":"DE Vaillancourt","year":"2000","unstructured":"Vaillancourt, D. E. & Newell, K. M. The dynamics of resting and postural tremor in Parkinson\u2019s disease. Clin. Neurophysiol. 111, 2046\u20132056 (2000).","journal-title":"Clin. Neurophysiol."},{"key":"521_CR44","doi-asserted-by":"publisher","first-page":"E2341","DOI":"10.3390\/s17102341","volume":"17","author":"S Aghanavesi","year":"2017","unstructured":"Aghanavesi, S., Memedi, M., Dougherty, M., Nyholm, D. & Westin, J. Verification of a method for measuring Parkinson\u2019s disease related temporal irregularity in spiral drawings. Sensors 17, E2341 (2017).","journal-title":"Sensors"},{"key":"521_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-4580(01)00247-0","volume":"23","author":"DE Vaillancourt","year":"2002","unstructured":"Vaillancourt, D. E. & Newell, K. M. Changing complexity in human behavior and physiology through aging and disease. Neurobiol. Aging 23, 1\u201311 (2002).","journal-title":"Neurobiol. Aging"},{"key":"521_CR46","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1109\/JBHI.2017.2777926","volume":"22","author":"I Thomas","year":"2018","unstructured":"Thomas, I. et al. A treatment-response index from wearable sensors for quantifying Parkinson\u2019s disease motor states. IEEE J. Biomed. Health Inform. 22, 1341\u20131349 (2018).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"521_CR47","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"521_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/japplphysiol.00060.2003","volume":"95","author":"EA Christou","year":"2003","unstructured":"Christou, E. A., Shinohara, M. & Enoka, R. M. Fluctuations in acceleration during voluntary contractions lead to greater impairment of movement accuracy in old adults. J. Appl. Physiol. 95, 373\u2013384 (2003).","journal-title":"J. Appl. Physiol."},{"key":"521_CR49","first-page":"5426","volume":"2018","author":"F Javed","year":"2018","unstructured":"Javed, F., Thomas, I. & Memedi, M. A comparison of feature selection methods when using motion sensors data: a case study in Parkinson\u2019s disease. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. 2018, 5426\u20135429 (2018).","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"key":"521_CR50","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/S1388-2457(00)00378-3","volume":"111","author":"DE Vaillancourt","year":"2000","unstructured":"Vaillancourt, D. E. & Newell, K. M. Amplitude changes in the 8-12, 20-25, and 40 Hz oscillations in finger tremor. Clin. Neurophysiol. 111, 1792\u20131801 (2000).","journal-title":"Clin. Neurophysiol."},{"key":"521_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmcj.2015.12.007","volume":"33","author":"S Mazilu","year":"2016","unstructured":"Mazilu, S. et al. The role of wrist-mounted inertial sensors in detecting gait freeze episodes in Parkinson\u2019s disease. Pervasive Mob. Comput. 33, 1\u201316 (2016).","journal-title":"Pervasive Mob. Comput."},{"key":"521_CR52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.clinph.2019.10.019","volume":"131","author":"BJ Wilkes","year":"2020","unstructured":"Wilkes, B. J. et al. Effects of ventral intermediate nucleus deep brain stimulation across multiple effectors in essential tremor. Clin. Neurophysiol. 131, 167\u2013176 (2020).","journal-title":"Clin. Neurophysiol."},{"key":"521_CR53","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1002\/hbm.24760","volume":"40","author":"T Mitchell","year":"2019","unstructured":"Mitchell, T. et al. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism. Hum. Brain Mapp. 40, 5094\u20135107 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"521_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/brain\/awx338","volume":"141","author":"DB Archer","year":"2018","unstructured":"Archer, D. B. et al. A widespread visually-sensitive functional network relates to symptoms in essential tremor. Brain 141, 472\u2013485 (2018).","journal-title":"Brain"},{"key":"521_CR55","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/S2589-7500(19)30105-0","volume":"1","author":"DB Archer","year":"2019","unstructured":"Archer, D. B. et al. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study. Lancet Digit. Health 1, e222\u2013e231 (2019).","journal-title":"Lancet Digit. Health"},{"key":"521_CR56","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak, O., Sochen, N., Gur, Y., Intrator, N. & Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62, 717\u2013730 (2009).","journal-title":"Magn. Reson. Med."},{"key":"521_CR57","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.neuroimage.2009.09.062","volume":"49","author":"BB Avants","year":"2010","unstructured":"Avants, B. B. et al. The optimal template effect in hippocampus studies of diseased populations. Neuroimage 49, 2457\u20132466 (2010).","journal-title":"Neuroimage"},{"key":"521_CR58","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/cercor\/bhx066","volume":"28","author":"DB Archer","year":"2018","unstructured":"Archer, D. B., Vaillancourt, D. E. & Coombes, S. A. A template and probabilistic atlas of the human sensorimotor tracts using diffusion MRI. Cereb. Cortex 28, 1685\u20131699 (2018).","journal-title":"Cereb. Cortex"},{"key":"521_CR59","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuroimage.2015.09.014","volume":"124","author":"KM van Baarsen","year":"2016","unstructured":"van Baarsen, K. M. et al. A probabilistic atlas of the cerebellar white matter. Neuroimage 124, 724\u2013732 (2016).","journal-title":"Neuroimage"},{"key":"521_CR60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Series B Stat. Methodol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00521-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T20:38:22Z","timestamp":1729543102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00521-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}